Insider Transactions in Q1 2024 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-0.05%
|
$22,356
$23.24 P/Share
|
Mar 01
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,553
-0.35%
|
$35,719
$23.24 P/Share
|
Mar 01
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-0.2%
|
$34,017
$23.24 P/Share
|
Feb 26
2024
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
35,636
+3.11%
|
-
|
Feb 26
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,529
-0.79%
|
$132,696
$24.26 P/Share
|
Feb 26
2024
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,721
+4.48%
|
-
|
Feb 26
2024
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,050
-1.36%
|
$433,200
$24.26 P/Share
|
Feb 26
2024
|
Paul Kim CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
34,862
+4.94%
|
-
|
Feb 26
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,719
-1.4%
|
$137,256
$24.26 P/Share
|
Feb 26
2024
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,377
+1.08%
|
-
|
Feb 26
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,290
-0.18%
|
$78,960
$24.26 P/Share
|
Feb 23
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,670
-1.35%
|
$64,080
$24.06 P/Share
|
Feb 23
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,617
-0.18%
|
$38,808
$24.06 P/Share
|
Feb 23
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,612
-0.76%
|
$62,688
$24.06 P/Share
|
Feb 23
2024
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,667
-1.35%
|
$208,008
$24.06 P/Share
|
Feb 03
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,719
-1.87%
|
$161,256
$24.65 P/Share
|
Feb 03
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-0.49%
|
$23,568
$24.65 P/Share
|
Feb 01
2024
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,094
-0.17%
|
$26,256
$24.99 P/Share
|
Jan 30
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.01%
|
$2,250
$25.0 P/Share
|
Jan 26
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,683
-1.29%
|
$117,075
$25.6 P/Share
|
Jan 26
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,325
-0.15%
|
$33,125
$25.6 P/Share
|
Jan 26
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-0.99%
|
$49,700
$25.6 P/Share
|